Rapid Micro Biosystems (RPID)
(Delayed Data from NSDQ)
$3.41 USD
-0.01 (-0.29%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $3.43 +0.02 (0.59%) 7:34 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Rapid Micro Biosystems, Inc. has a market cap of $149.90M, which represents its share price of $3.42 multiplied by its outstanding shares number of 43.83M. As a small-cap company, RPID's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RPID 3.41 -0.01(-0.29%)
Will RPID be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RPID based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RPID
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
Thermo Fisher Scientific (TMO) Tops Q2 Earnings and Revenue Estimates
RPID: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates
Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates
Other News for RPID
Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025 | ...
Lake Street Initiates Coverage on Rapid Micro Biosystems (RPID) with Buy Rating | RPID Stock News
Lake Street Initiates Coverage on Rapid Micro Biosystems (RPID) with Positive Outlook
Rapid Micro Biosystems initiated with bullish view at Lake Street, here's why
Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'